Treatment success rate: previously treated TB cases in Lithuania
Lithuania: Treatment success rate: previously treated TB cases was 75 in 2023. ▲ Rising
Treatment success rate: previously treated TB cases in Lithuania, 1998–2023
Source: World Health Organization, Global Health Observatory.
Analysis
In 2023, treatment success rate: previously treated tb cases in Lithuania stood at 75.
Compared with earlier readings it is up 11.9% on the previous year and up 102.7% over ten years.
Over the whole period, treatment success rate: previously treated tb cases in Lithuania peaked at 90 in 2020 and was at its lowest, 28, in 2009.
Lithuania ranks 72nd of 179 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Treatment success rate: previously treated TB cases in Lithuania, year by year
| Year | Value | Change |
|---|---|---|
| 1998 | 79 | — |
| 1999 | 43 | -45.6% |
| 2000 | 45 | +4.7% |
| 2001 | 38 | -15.6% |
| 2002 | 39 | +2.6% |
| 2003 | 32 | -17.9% |
| 2004 | 32 | +0.0% |
| 2005 | 29 | -9.4% |
| 2006 | 36 | +24.1% |
| 2007 | 30 | -16.7% |
| 2008 | 35 | +16.7% |
| 2009 | 28 | -20.0% |
| 2010 | 32 | +14.3% |
| 2011 | 33 | +3.1% |
| 2012 | 57 | +72.7% |
| 2013 | 37 | -35.1% |
| 2014 | 46 | +24.3% |
| 2015 | 48 | +4.3% |
| 2016 | 69 | +43.8% |
| 2017 | 57 | -17.4% |
| 2018 | 70 | +22.8% |
| 2019 | 84 | +20.0% |
| 2020 | 90 | +7.1% |
| 2021 | 54 | -40.0% |
| 2022 | 67 | +24.1% |
| 2023 | 75 | +11.9% |
Lithuania compared with similar countries
- Lithuania's 75 is above the median for high income countries, which is 65.5, 1.1× the median. (54 countries reporting)
- Lithuania's 75 is above the median for Europe & Central Asia, which is 69, 1.1× the median. (47 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 61 | 43 | 79 | 2 |
| 2000s | 34.4 | 28 | 45 | 10 |
| 2010s | 53.3 | 32 | 84 | 10 |
| 2020s | 71.5 | 54 | 90 | 4 |
Countries ranked near Lithuania
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,909 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -4.51 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0199 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.59 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment success rate: previously treated tb cases in Lithuania?
- Treatment success rate: previously treated tb cases in Lithuania was 75 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: previously treated tb cases recorded in Lithuania?
- The highest recorded value was 90 in 2020.
- What is the lowest treatment success rate: previously treated tb cases recorded in Lithuania?
- The lowest recorded value was 28 in 2009.
- How does Lithuania rank for treatment success rate: previously treated tb cases?
- Lithuania ranks 72nd out of 179 countries with data for 2023.
- Is treatment success rate: previously treated tb cases rising or falling in Lithuania?
- Over the last ten years it is up 102.7%. The long-run trend across the full record is rising.
- Where does this Lithuania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: previously treated TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).